BURLINGTON, Mass., May 23, 2024
/PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that
Company management will participate in the Jefferies Global
Healthcare Conference in New York,
NY, on Wednesday, June 5,
2024, which includes a presentation beginning at
11:00 am ET. The live webcast can be
accessed through the Azenta investor relations website at
https://investors.azenta.com/events. A replay of the webcast will
be available following the event.
About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life
sciences solutions worldwide, enabling impactful breakthroughs and
therapies to market faster. Azenta provides a full suite of
reliable cold-chain sample management solutions and multiomics
services across areas such as drug development, clinical research
and advanced cell therapies for the industry's top pharmaceutical,
biotech, academic and healthcare institutions globally. Our global
team delivers and supports these products and services through our
industry-leading brands, including GENEWIZ, FluidX, Ziath, 4titude,
Limfinity, Freezer Pro, Barkey and B Medical Systems.
Azenta is headquartered in Burlington, MA, with operations
in North America, Europe and Asia. For more
information, please visit www.azenta.com.
INVESTOR CONTACTS:
Yvonne Perron
Vice President, Financial, Planning & Analysis and Investor
Relations
ir@azenta.com
Sherry Dinsmore
sherry.dinsmore@azenta.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/azenta-to-participate-in-the-jefferies-global-healthcare-conference-302154647.html
SOURCE Azenta